Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs JPMorgan Chase & Co — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43 (market cap $7.04B), while JPMorgan Chase & Co trades at $337.15 (market cap $880.15B). The key difference: JPMorgan Chase & Co is far larger — about 125× Ionis Pharmaceuticals Inc. Common Stock's market cap, and JPMorgan Chase & Co pays a 1.99% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and JPMorgan Chase & Co for 127 Days on average.
| IONS | JPM | |
|---|---|---|
Market Cap | $7.04B | $880.15B |
Volume | 2,977,440 | 13,756,367 |
Sector | Health | Financials |
52-Week High | $86.50 | $365.18 |
52-Week Low | $42.38 | $282.84 |
Typical Hold Time | 0 Days | 127 Days |
Enterprise Value | $6.60B | $1.40T |
Dividend Yield | — | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPMorgan Chase (JPM) trades at $331.43, down 0.86% on the day, with a bearish technical signal despite strong fundamentals. The company reported mixed Q3 2026 earnings but beat expectations in Q1 and Q2, with revenue growing to $181.85B in 2025. Analyst consensus remains positive with a $373.36 price target, though technical indicators show resistance near $336-339 levels.
JPMorgan offers solid investment potential with strong profitability (33.38% net margin) and attractive valuation (P/E 13.9), but faces headwinds from negative cash flow trends and geopolitical risks highlighted in recent CEO warnings. The stock's current technical weakness suggests near-term consolidation before potential upside toward analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
